Pharsight

CELLECTIS PATENTS FACING OPPOSITIONS

Top patents of CELLECTIS facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3116902B1 01 Jan, 2020 Method For Generating T-Cells Compatible For Allogenic Transplantation NA 4
EP3008186B1 28 Nov, 2018 Methods For Non-Transgenic Genome Editing In Plants NA 4
EP3105317B1 19 Sep, 2018 Cells For Immunotherapy Engineered For Targeting Antigen Present Both On Immune Cells And Pathological Cells NA 2
EP2997141B1 12 Oct, 2022 Cd19 Specific Chimeric Antigen Receptor And Uses Thereof May, 2034 1
EP3189073B1 25 Dec, 2019 Trophoblast Glycoprotein (5T4, Tpbg) Specific Chimeric Antigen Receptors For Cancer Immunotherapy NA 1
EP3126390B1 16 Oct, 2019 Cd33 Specific Chimeric Antigen Receptors For Cancer Immunotherapy NA 1
EP3004349B1 28 Mar, 2018 A Method For Producing Precise Dna Cleavage Using Cas9 Nickase Activity NA 1
EP3004337B1 02 Aug, 2017 Methods For Engineering T Cells For Immunotherapy By Using Rna-Guided Cas Nuclease System NA 1